$GTCB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in rEVO Biologics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in rEVO Biologics, Inc.. Get notifications about new insider transactions in rEVO Biologics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 01 2010 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.32 | 5,859 | 1,875 | 21,226 | 15.4 K to 21.2 K (+38.13 %) |
| Oct 01 2010 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.32 | 4,688 | 1,500 | 16,797 | 12.1 K to 16.8 K (+38.72 %) |
| Jul 06 2010 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.46 | 3,261 | 1,500 | 12,109 | 8.8 K to 12.1 K (+36.86 %) |
| Jul 06 2010 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.46 | 2,174 | 1,000 | 8,494 | 6.3 K to 8.5 K (+34.40 %) |
| Jul 06 2010 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.46 | 4,076 | 1,875 | 15,367 | 11.3 K to 15.4 K (+36.10 %) |
| Jun 17 2010 | GTCB | rEVO Biologics, In ... | HEIDEN WILLIAM K | Chairman, President ... | Option Exercise | A | 0.42 | 300,000 | 126,000 | 300,000 | |
| Apr 05 2010 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.55 | 3,409 | 1,875 | 11,291 | 7.9 K to 11.3 K (+43.25 %) |
| Apr 05 2010 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.55 | 2,727 | 1,500 | 8,848 | 6.1 K to 8.8 K (+44.55 %) |
| Apr 05 2010 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.55 | 1,818 | 1,000 | 6,320 | 4.5 K to 6.3 K (+40.38 %) |
| Jan 08 2010 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | C | 2.24 | 6,750 | 15,098 | 0 | |
| Jan 08 2010 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | C | 2.63 | 6,000 | 15,780 | 0 | |
| Jan 08 2010 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Buy | C | 2.24 | 3,017,703 | 6,749,998 | 21,299,906 | 18.3 M to 21.3 M (+16.51 %) |
| Jan 08 2010 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Buy | C | 2.63 | 2,281,368 | 5,999,998 | 18,282,203 | 16 M to 18.3 M (+14.26 %) |
| Feb 12 2010 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | P | 1.08 | 14,798 | 15,982 | 14,798 | 0 to 14.8 K |
| Feb 12 2010 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Sell | S | 1.13 | 14,798 | 16,648 | 0 | 14.8 K to 0 (-100.00 %) |
| Jan 05 2010 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.75 | 1,333 | 1,000 | 4,502 | 3.2 K to 4.5 K (+42.06 %) |
| Jan 05 2010 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.75 | 2,500 | 1,875 | 7,882 | 5.4 K to 7.9 K (+46.45 %) |
| Jan 05 2010 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 0.75 | 4,000 | 3,000 | 19,025 | 15 K to 19 K (+26.62 %) |
| Jan 05 2010 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.75 | 2,000 | 1,500 | 6,121 | 4.1 K to 6.1 K (+48.53 %) |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | M | 2.24 | 6,750 | 15,098 | 6,750 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | M | 2.63 | 6,000 | 15,780 | 6,000 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | M | 1,000.00 | 6,750 | 6,750,000 | 0 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | M | 1,000.00 | 6,000 | 6,000,000 | 0 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | C | 2.24 | 13,500 | 30,197 | 0 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | C | 2.63 | 12,000 | 31,560 | 0 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | A | 1,000.00 | 6,750 | 6,750,000 | 6,750 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | A | 1,000.00 | 6,000 | 6,000,000 | 6,000 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | P | 2.24 | 13,500 | 30,197 | 13,500 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Option Exercise | P | 2.63 | 12,000 | 31,560 | 12,000 | |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Buy | P | 1.07 | 3,387,851 | 3,625,001 | 16,000,835 | 12.6 M to 16 M (+26.86 %) |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Buy | C | 2.24 | 6,035,407 | 13,499,998 | 12,612,984 | 6.6 M to 12.6 M (+91.76 %) |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | Director by Deputiz ... | Buy | C | 2.63 | 4,562,737 | 11,999,998 | 6,577,577 | 2 M to 6.6 M (+226.46 %) |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Grant | A | 1.21 | 11,268 | 13,634 | 21,899 | 10.6 K to 21.9 K (+105.99 %) |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 1.21 | 13,722 | 16,604 | 28,173 | 14.5 K to 28.2 K (+94.96 %) |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 1.21 | 31,626 | 38,267 | 87,944 | 56.3 K to 87.9 K (+56.16 %) |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Grant | A | 1.21 | 13,598 | 16,454 | 29,452 | 15.9 K to 29.5 K (+85.77 %) |
| Nov 04 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 1.21 | 11,717 | 14,178 | 22,033 | 10.3 K to 22 K (+113.58 %) |
| Oct 05 2009 | GTCB | rEVO Biologics, In ... | HEIDEN WILLIAM K | Director | Option Exercise | A | 1.52 | 3,000 | 4,560 | 3,000 | |
| Sep 28 2009 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 1.76 | 569 | 1,000 | 3,169 | 2.6 K to 3.2 K (+21.88 %) |
| Sep 28 2009 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.76 | 683 | 1,201 | 3,585 | 2.9 K to 3.6 K (+23.54 %) |
| Sep 28 2009 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 1.76 | 1,564 | 2,750 | 15,025 | 13.5 K to 15 K (+11.62 %) |
| Sep 28 2009 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 1.76 | 1,067 | 1,876 | 5,382 | 4.3 K to 5.4 K (+24.73 %) |
| Sep 28 2009 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 1.76 | 853 | 1,500 | 4,121 | 3.3 K to 4.1 K (+26.10 %) |
| Sep 28 2009 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 1.76 | 2,844 | 5,000 | 13,348 | 10.5 K to 13.3 K (+27.08 %) |
| Jul 02 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Payment of Exercise | F | 2.66 | 2,331 | 6,200 | 56,318 | 58.6 K to 56.3 K (-3.97 %) |
| Jul 02 2009 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Payment of Exercise | F | 2.66 | 1,165 | 3,099 | 10,631 | 11.8 K to 10.6 K (-9.88 %) |
| Jul 02 2009 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Payment of Exercise | F | 2.66 | 1,165 | 3,099 | 15,854 | 17 K to 15.9 K (-6.85 %) |
| Jul 02 2009 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Payment of Exercise | F | 2.66 | 1,165 | 3,099 | 14,451 | 15.6 K to 14.5 K (-7.46 %) |
| Jul 02 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Payment of Exercise | F | 2.66 | 1,165 | 3,099 | 10,316 | 11.5 K to 10.3 K (-10.15 %) |
| Jun 29 2009 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 2.70 | 1,019 | 2,751 | 13,461 | 12.4 K to 13.5 K (+8.19 %) |
| Jun 29 2009 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 2.70 | 694 | 1,874 | 4,315 | 3.6 K to 4.3 K (+19.17 %) |
| Jun 29 2009 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 2.70 | 1,852 | 5,000 | 10,504 | 8.7 K to 10.5 K (+21.41 %) |
| Jun 29 2009 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 2.70 | 370 | 999 | 2,600 | 2.2 K to 2.6 K (+16.59 %) |
| Jun 29 2009 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 2.70 | 444 | 1,199 | 2,902 | 2.5 K to 2.9 K (+18.06 %) |
| Jun 29 2009 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 2.70 | 556 | 1,501 | 3,268 | 2.7 K to 3.3 K (+20.50 %) |
| May 29 2009 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Option Exercise | A | 3.05 | 4,500 | 13,725 | 4,500 | |
| May 29 2009 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Option Exercise | A | 3.05 | 4,500 | 13,725 | 4,500 | |
| May 29 2009 | GTCB | rEVO Biologics, In ... | Bauer Kenneth | Director | Option Exercise | A | 3.05 | 4,500 | 13,725 | 4,500 | |
| May 29 2009 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Option Exercise | A | 3.05 | 4,500 | 13,725 | 4,500 | |
| Apr 01 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 0.37 | 35,000 | 12,950 | 35,000 | |
| Apr 01 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 0.37 | 110,000 | 40,700 | 110,000 | |
| Apr 01 2009 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Option Exercise | A | 0.37 | 35,000 | 12,950 | 35,000 | |
| Apr 01 2009 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 0.37 | 35,000 | 12,950 | 35,000 | |
| Apr 01 2009 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Option Exercise | A | 0.37 | 50,000 | 18,500 | 50,000 | |
| Mar 31 2009 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 0.33 | 8,333 | 2,750 | 124,426 | 116.1 K to 124.4 K (+7.18 %) |
| Mar 31 2009 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 0.33 | 15,152 | 5,000 | 86,563 | 71.4 K to 86.6 K (+21.22 %) |
| Mar 31 2009 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.33 | 5,682 | 1,875 | 36,210 | 30.5 K to 36.2 K (+18.61 %) |
| Mar 31 2009 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.33 | 3,636 | 1,200 | 24,584 | 20.9 K to 24.6 K (+17.36 %) |
| Mar 31 2009 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.33 | 3,030 | 1,000 | 22,307 | 19.3 K to 22.3 K (+15.72 %) |
| Mar 31 2009 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.33 | 4,545 | 1,500 | 27,126 | 22.6 K to 27.1 K (+20.13 %) |
| Feb 05 2009 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 5,400 | 0 | 114,825 | 109.4 K to 114.8 K (+4.93 %) |
| Feb 05 2009 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Grant | A | 0.00 | 5,400 | 0 | 117,974 | 112.6 K to 118 K (+4.80 %) |
| Feb 05 2009 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Grant | A | 0.00 | 5,400 | 0 | 170,212 | 164.8 K to 170.2 K (+3.28 %) |
| Feb 05 2009 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 0.00 | 5,400 | 0 | 156,170 | 150.8 K to 156.2 K (+3.58 %) |
| Feb 05 2009 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 10,800 | 0 | 586,517 | 575.7 K to 586.5 K (+1.88 %) |
| Dec 31 2008 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Option Exercise | P | 0.31 | 23,193,548 | 7,190,000 | 23,193,548 | |
| Dec 31 2008 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Option Exercise | P | 0.31 | 48,387,096 | 15,000,000 | 48,387,096 | |
| Dec 31 2008 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | 10% Owner | Option Exercise | P | 0.31 | 23,193,548 | 7,190,000 | 23,193,548 | |
| Dec 31 2008 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | 10% Owner | Option Exercise | P | 0.31 | 48,387,096 | 15,000,000 | 48,387,096 | |
| Dec 29 2008 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.28 | 3,591 | 1,000 | 19,277 | 15.7 K to 19.3 K (+22.89 %) |
| Dec 29 2008 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.28 | 5,386 | 1,500 | 22,581 | 17.2 K to 22.6 K (+31.32 %) |
| Dec 29 2008 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.28 | 4,309 | 1,200 | 20,948 | 16.6 K to 20.9 K (+25.90 %) |
| Dec 29 2008 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 0.28 | 9,874 | 2,750 | 116,093 | 106.2 K to 116.1 K (+9.30 %) |
| Dec 29 2008 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.28 | 6,732 | 1,875 | 30,528 | 23.8 K to 30.5 K (+28.29 %) |
| Dec 29 2008 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 0.28 | 17,953 | 5,000 | 71,411 | 53.5 K to 71.4 K (+33.58 %) |
| Dec 11 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 0.31 | 100,000 | 31,000 | 100,000 | |
| Dec 11 2008 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 0.31 | 100,000 | 31,000 | 100,000 | |
| Dec 11 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 0.31 | 160,000 | 49,600 | 160,000 | |
| Dec 11 2008 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Option Exercise | A | 0.31 | 100,000 | 31,000 | 100,000 | |
| Dec 11 2008 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Option Exercise | A | 0.31 | 100,000 | 31,000 | 100,000 | |
| Nov 24 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.15 | 1,500 | 225 | 575,717 | 574.2 K to 575.7 K (+0.26 %) |
| Nov 24 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.16 | 40,900 | 6,544 | 574,217 | 533.3 K to 574.2 K (+7.67 %) |
| Nov 24 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.17 | 43,600 | 7,412 | 533,317 | 489.7 K to 533.3 K (+8.90 %) |
| Sep 29 2008 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.37 | 3,243 | 1,200 | 16,639 | 13.4 K to 16.6 K (+24.21 %) |
| Sep 29 2008 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.37 | 2,703 | 1,000 | 15,686 | 13 K to 15.7 K (+20.82 %) |
| Sep 29 2008 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 0.37 | 7,432 | 2,750 | 106,219 | 98.8 K to 106.2 K (+7.52 %) |
| Sep 29 2008 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.37 | 5,068 | 1,875 | 23,796 | 18.7 K to 23.8 K (+27.06 %) |
| Sep 29 2008 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 0.37 | 13,514 | 5,000 | 53,458 | 39.9 K to 53.5 K (+33.83 %) |
| Jul 03 2008 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Grant | A | 0.00 | 30,600 | 0 | 164,812 | 134.2 K to 164.8 K (+22.80 %) |
| Sep 29 2008 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.37 | 4,054 | 1,500 | 17,195 | 13.1 K to 17.2 K (+30.85 %) |
| Jul 03 2008 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 0.00 | 30,600 | 0 | 150,700 | 120.1 K to 150.7 K (+25.48 %) |
| Jul 03 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 61,200 | 0 | 489,717 | 428.5 K to 489.7 K (+14.28 %) |
| Jul 03 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 30,600 | 0 | 109,425 | 78.8 K to 109.4 K (+38.82 %) |
| Jul 03 2008 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Grant | A | 0.00 | 30,600 | 0 | 112,574 | 82 K to 112.6 K (+37.33 %) |
| Jun 30 2008 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.40 | 4,664 | 1,875 | 18,728 | 14.1 K to 18.7 K (+33.16 %) |
| Jun 30 2008 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 0.40 | 6,841 | 2,750 | 98,787 | 91.9 K to 98.8 K (+7.44 %) |
| Jun 30 2008 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.40 | 2,985 | 1,200 | 13,396 | 10.4 K to 13.4 K (+28.67 %) |
| Jun 30 2008 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.40 | 3,731 | 1,500 | 13,141 | 9.4 K to 13.1 K (+39.65 %) |
| Jun 30 2008 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 0.40 | 12,438 | 5,000 | 39,944 | 27.5 K to 39.9 K (+45.22 %) |
| Jun 30 2008 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.40 | 2,488 | 1,000 | 12,983 | 10.5 K to 13 K (+23.71 %) |
| Jun 25 2008 | GTCB | rEVO Biologics, In ... | GRAY MARY ANN | Director | Option Exercise | A | 0.39 | 45,000 | 17,667 | 45,000 | |
| Jun 25 2008 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Option Exercise | A | 0.39 | 45,000 | 17,667 | 45,000 | |
| Jun 25 2008 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Option Exercise | A | 0.39 | 45,000 | 17,667 | 45,000 | |
| Apr 01 2008 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 0.55 | 9,091 | 5,000 | 27,506 | 18.4 K to 27.5 K (+49.37 %) |
| Apr 01 2008 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.55 | 2,727 | 1,500 | 9,410 | 6.7 K to 9.4 K (+40.81 %) |
| Apr 01 2008 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.55 | 2,182 | 1,200 | 10,411 | 8.2 K to 10.4 K (+26.52 %) |
| Apr 01 2008 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.55 | 1,818 | 1,000 | 10,495 | 8.7 K to 10.5 K (+20.95 %) |
| Apr 01 2008 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 0.55 | 5,000 | 2,750 | 91,946 | 86.9 K to 91.9 K (+5.75 %) |
| Apr 01 2008 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.55 | 3,409 | 1,875 | 14,064 | 10.7 K to 14.1 K (+31.99 %) |
| Mar 27 2008 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Option Exercise | C | 0.00 | 14,500 | 0 | 115 | |
| Mar 27 2008 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Buy | C | 0.00 | 14,500,000 | 0 | 20,148,404 | 5.6 M to 20.1 M (+256.71 %) |
| Mar 27 2008 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | 10% Owner | Option Exercise | C | 0.00 | 14,500 | 0 | 115 | |
| Mar 27 2008 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | 10% Owner | Buy | C | 0.00 | 14,500,000 | 0 | 20,148,404 | 5.6 M to 20.1 M (+256.71 %) |
| Mar 13 2008 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Sell | S | 0.57 | 1,175 | 671 | 45,336 | 46.5 K to 45.3 K (-2.53 %) |
| Mar 13 2008 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Sell | S | 0.57 | 7,255 | 4,135 | 46,511 | 53.8 K to 46.5 K (-13.49 %) |
| Mar 13 2008 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Sell | S | 0.56 | 14,500 | 8,120 | 53,766 | 68.3 K to 53.8 K (-21.24 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.50 | 12,260 | 6,130 | 428,517 | 416.3 K to 428.5 K (+2.95 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.49 | 3,900 | 1,911 | 416,257 | 412.4 K to 416.3 K (+0.95 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.48 | 13,740 | 6,595 | 412,357 | 398.6 K to 412.4 K (+3.45 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.47 | 63,100 | 29,657 | 398,617 | 335.5 K to 398.6 K (+18.81 %) |
| Mar 17 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.46 | 7,400 | 3,404 | 335,517 | 328.1 K to 335.5 K (+2.26 %) |
| Mar 12 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Sell | S | 0.57 | 17,000 | 9,699 | 78,825 | 95.8 K to 78.8 K (-17.74 %) |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Option Exercise | A | 0.63 | 25,000 | 15,750 | 25,000 | |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Grant | A | 0.00 | 27,645 | 0 | 81,974 | 54.3 K to 82 K (+50.88 %) |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Option Exercise | A | 0.63 | 25,000 | 15,750 | 25,000 | |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Grant | A | 0.00 | 34,986 | 0 | 134,212 | 99.2 K to 134.2 K (+35.26 %) |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 0.63 | 25,000 | 15,750 | 25,000 | |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 0.00 | 32,970 | 0 | 120,170 | 87.2 K to 120.2 K (+37.81 %) |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Option Exercise | A | 0.63 | 25,000 | 15,750 | 25,000 | |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Grant | A | 0.00 | 33,618 | 0 | 68,266 | 34.6 K to 68.3 K (+97.03 %) |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 0.63 | 75,000 | 47,250 | 75,000 | |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 73,442 | 0 | 328,117 | 254.7 K to 328.1 K (+28.84 %) |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 0.63 | 25,000 | 15,750 | 25,000 | |
| Mar 10 2008 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 30,491 | 0 | 95,825 | 65.3 K to 95.8 K (+46.67 %) |
| Feb 25 2008 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | 10% Owner | Buy | P | 0.87 | 2,018,404 | 1,756,011 | 5,648,404 | 3.6 M to 5.6 M (+55.60 %) |
| Feb 25 2008 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Buy | P | 0.87 | 2,018,404 | 1,756,011 | 5,648,404 | 3.6 M to 5.6 M (+55.60 %) |
| Jan 08 2008 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.72 | 693 | 501 | 254,675 | 254 K to 254.7 K (+0.27 %) |
| Jan 08 2008 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | J | 0.72 | 693 | 501 | 54,329 | 53.6 K to 54.3 K (+1.29 %) |
| Dec 28 2007 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 0.87 | 1,149 | 1,000 | 8,677 | 7.5 K to 8.7 K (+15.26 %) |
| Dec 28 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.87 | 1,379 | 1,200 | 8,229 | 6.9 K to 8.2 K (+20.13 %) |